GI Panel (17 x 0.25mL; 2 x 0.85 mL)

ZeptoMetrix external controls have demonstrated performance on a variety of molecular assays. The product has been tested with the Applied BioCode MDx 3000 systemand provides the expected results, however performance characteristics must be established by the end user.

NATtrol GI Panel includes 17 targets: Salmonella enterica typhimurium strain Z005; Escherichia coli strain EDL933; Escherichia coli strains 92.0147, EAEC; Escherichia coli strains ETEC, ST+, LT+; Escherichia coli strains 7.1493, O84:H28, EPEC; Shigella sonnei strain Z004; Entamoeba histolytica strain DS4-868; Vibrio parahaemolyticus strain Z134; Cryptosporidium parvum strain Iowa; Clostridium difficile strain NAP1; Campylobacter jejuni Clinical isolate; Yersinia enterocolitica Clinical isolate; Rotavirus strain Wa; Norovirus GI Recombinant; Norovirus GII Recombinant; Adenovirus Type 41 strain TAK; and Vibrio cholerae strain Z133, nontoxigenic.

• Formulated with purified, intact organisms

• Organisms are chemically modified to render them noninfectious

• Refrigerator stable—store between 2 and 8°C

• Purified protein matrix treated with 0.09% sodium azide

• 17 x 0.25 mL vials of NATtrol GI targets and 2 x 0.85 mL vials of the negative matrix

NATtrol products are ready-to-use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel and to monitor assay-kit lot performance. NATtrol products contain intact organisms and should be run in a manner similar to clinical specimens.

• ENGLISH (PI)
• ENGLISH (SDS)

For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.

When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.